207 related articles for article (PubMed ID: 29582584)
1. Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue.
Bohlen J; McLaughlin SL; Hazard-Jenkins H; Infante AM; Montgomery C; Davis M; Pistilli EE
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):701-714. PubMed ID: 29582584
[TBL] [Abstract][Full Text] [Related]
2. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis.
Croci S; Nanni P; Palladini A; Nicoletti G; Grosso V; Benegiamo G; Landuzzi L; Lamolinara A; Ianzano ML; Ranieri D; Dall'Ora M; Iezzi M; De Giovanni C; Lollini PL
Breast Cancer Res; 2015 May; 17(1):70. PubMed ID: 25997501
[TBL] [Abstract][Full Text] [Related]
4. Human Breast Cancer Xenograft Model Implicates Peroxisome Proliferator-activated Receptor Signaling as Driver of Cancer-induced Muscle Fatigue.
Wilson HE; Rhodes KK; Rodriguez D; Chahal I; Stanton DA; Bohlen J; Davis M; Infante AM; Hazard-Jenkins H; Klinke DJ; Pugacheva EN; Pistilli EE
Clin Cancer Res; 2019 Apr; 25(7):2336-2347. PubMed ID: 30559167
[TBL] [Abstract][Full Text] [Related]
5. Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.
Lefley D; Howard F; Arshad F; Bradbury S; Brown H; Tulotta C; Eyre R; Alférez D; Wilkinson JM; Holen I; Clarke RB; Ottewell P
Breast Cancer Res; 2019 Nov; 21(1):130. PubMed ID: 31783893
[TBL] [Abstract][Full Text] [Related]
6. Sexual Dimorphism of Skeletal Muscle in a Mouse Model of Breast Cancer: A Functional and Molecular Analysis.
Rentz LE; Whetsell MA; Clayton SA; Mizener AD; Holásková I; Chapa MG; Hoblitzell EH; Eubank TD; Pistilli EE
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511427
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia.
Judge SM; Wu CL; Beharry AW; Roberts BM; Ferreira LF; Kandarian SC; Judge AR
BMC Cancer; 2014 Dec; 14():997. PubMed ID: 25539728
[TBL] [Abstract][Full Text] [Related]
8. Muscle-specific deletion of exons 2 and 3 of the IL15RA gene in mice: effects on contractile properties of fast and slow muscles.
O'Connell G; Guo G; Stricker J; Quinn LS; Ma A; Pistilli EE
J Appl Physiol (1985); 2015 Feb; 118(4):437-48. PubMed ID: 25505029
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
Dagher E; Royer V; Buchet P; Abadie J; Loussouarn D; Campone M; Nguyen F
BMC Cancer; 2019 Dec; 19(1):1267. PubMed ID: 31888566
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome Analysis of Immune Receptor Activation and Energy Metabolism Reduction as the Underlying Mechanisms in Interleukin-6-Induced Skeletal Muscle Atrophy.
Sun H; Sun J; Li M; Qian L; Zhang L; Huang Z; Shen Y; Law BY; Liu L; Gu X
Front Immunol; 2021; 12():730070. PubMed ID: 34552592
[TBL] [Abstract][Full Text] [Related]
11. ∆Np63/p40 correlates with the location and phenotype of basal/mesenchymal cancer stem-like cells in human ER
Liu Y; Nekulova M; Nenutil R; Horakova I; Appleyard MV; Murray K; Holcakova J; Galoczova M; Quinlan P; Jordan LB; Purdie CA; Vojtesek B; Thompson AM; Coates PJ
J Pathol Clin Res; 2020 Jan; 6(1):83-93. PubMed ID: 31591823
[TBL] [Abstract][Full Text] [Related]
12. Muscle oxidative capacity during IL-6-dependent cancer cachexia.
White JP; Baltgalvis KA; Puppa MJ; Sato S; Baynes JW; Carson JA
Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R201-11. PubMed ID: 21148472
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia.
Constantinou C; Fontes de Oliveira CC; Mintzopoulos D; Busquets S; He J; Kesarwani M; Mindrinos M; Rahme LG; Argilés JM; Tzika AA
Int J Mol Med; 2011 Jan; 27(1):15-24. PubMed ID: 21069263
[TBL] [Abstract][Full Text] [Related]
15. Profiling the tyrosine phosphoproteome of different mouse mammary tumour models reveals distinct, model-specific signalling networks and conserved oncogenic pathways.
Ali NA; Wu J; Hochgräfe F; Chan H; Nair R; Ye S; Zhang L; Lyons RJ; Pinese M; Lee HC; Armstrong N; Ormandy CJ; Clark SJ; Swarbrick A; Daly RJ
Breast Cancer Res; 2014 Sep; 16(5):437. PubMed ID: 25200860
[TBL] [Abstract][Full Text] [Related]
16. IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ, SIRT1, PGC-1α, and PGC-1β expression in male mice.
Quinn LS; Anderson BG; Conner JD; Wolden-Hanson T
Endocrinology; 2013 Jan; 154(1):232-45. PubMed ID: 23161867
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.
Wilson HE; Stanton DA; Rellick S; Geldenhuys W; Pistilli EE
Am J Physiol Cell Physiol; 2021 Apr; 320(4):C577-C590. PubMed ID: 33439777
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts.
Clayton SA; Mizener AD; Whetsell M; Rentz LE; Meadows E; Geldenhuys W; Pistilli EE
bioRxiv; 2024 Apr; ():. PubMed ID: 38659807
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
[TBL] [Abstract][Full Text] [Related]
20. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
